ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1399	National Cancer Institute	Html	en	Nausea and Vomiting Related to Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about nausea and vomiting as complications of cancer or its treatment. Approaches to the management of nausea and vomiting are discussed.	cancer treatment 0.379171 chemotherapy session 0.416704 past chemotherapy treatments 0.404595 motion sickness 0.3776 chemotherapy 0.552867 PDQ cancer information 0.463652 chemotherapy treatment 0.441369 late nausea 0.506038 anticipatory nausea 0.711385 clinical trials 0.378644 vomiting 0.900093 Vomiting Related 0.471509 cancer information summary 0.41736 patients 0.393418 earlier chemotherapy session 0.400031 treatment room 0.360635 NCI’s PDQ 0.353745 nausea 0.98576 NCI PDQ cancer 0.3835 radiation therapy 0.495467 antinausea drugs 0.406187 involuntary body functions 0.353798 certain chemotherapy drugs 0.416814 following treatment factors 0.366128	radiation therapy treatments 0.356798 treatment 0.558325 gastrointestinal tract 0.416866 following table 0.366172 delayed nausea 0.530808 Cancer Information Service 0.360675 following patient factors 0.352013 previous chemotherapy sessions 0.394908 patient 0.370352 treatment clinical trials 0.357831 National Cancer Institute 0.420163 Palliative Care Editorial 0.381728 new treatment 0.358991 chronic nausea 0.490418 drugs 0.426328 Cancer Care page 0.352418 Care Editorial Board 0.382615 chemotherapy sessions 0.400414 PDQ summary 0.40058 Nausea section 0.481663 cancer information summaries 0.360345 comprehensive cancer information 0.360198 cancer therapy 0.357442 acute nausea 0.484601	CLICK HERE
1546	National Cancer Institute	Html	en	AIDS-Related Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.	cancer treatment 0.383886 AIDS-Related Lymphoma Treatment 0.393286 cancer spreads 0.326687 malignant tumor cells 0.309541 body 0.433918 chemotherapy 0.309155 PDQ cancer information 0.394743 clinical trial search 0.3032 white blood cells 0.3776 clinical trials 0.731846 cancer information summary 0.354741 clinical trial 0.454136 AIDS-related peripheral/systemic lymphoma 0.466219 patients 0.380662 blood cells 0.399358 old blood cells 0.295369 AIDS-related lymphomas 0.315773 treatment clinical trial 0.296684 NCI PDQ cancer 0.309251 lymph nodes 0.464743 large B-cell lymphoma 0.331734 radiation therapy 0.344733 Treatment Editorial Board 0.312981 lymph node groups 0.478813 treatment 0.574951	swollen lymph nodes 0.339153 cancer cells 0.476016 lymph node group 0.321747 specific cancer cells 0.306685 AIDS-related non-Hodgkin lymphoma 0.392687 primary cns lymphoma 0.430113 treatment clinical trials 0.33124 National Cancer Institute 0.355357 aids-related lymphoma 0.927549 lymph vessels 0.351707 new treatment 0.337577 External radiation therapy 0.327164 B-cell immunoblastic lymphoma 0.332379 AIDS-related primary CNS 0.358458 bone marrow 0.523968 cancer clinical trials 0.341952 stage 0.313358 treatment options 0.307053 nervous system lymphoma 0.295273 cancer 0.766753 standard treatment 0.309541 lymph tissue 0.333823 body lymphoma 0.323497 Burkitt-like lymphoma 0.311372	CLICK HERE
1585	National Cancer Institute	Html	en	Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Patient Version	Multiple myeloma, plasmacytoma, lymphoplasmacytic lymphoma, and monoclonal gammopathy of undetermined significance (MGUS) are different types of plasma cell neoplasms. Find out about risk factors, symptoms, tests to diagnose, prognosis, stages, and treatment for these diseases.	red blood cells 0.474629 myeloma cells 0.443938 cancer treatment 0.407402 Myeloma treatment options 0.373753 biologic therapy 0.382101 blood -forming cells 0.372128 body 0.40943 type 0.393577 PDQ cancer information 0.415525 bone marrow aspiration 0.378402 clinical trial search 0.419003 white blood cells 0.422631 clinical trials 0.689828 mature blood cells 0.378353 abnormal plasma cells 0.479263 cancer information summary 0.39289 clinical trial 0.492432 stem cells 0.378 multiple myeloma 0.975001 patients 0.39195 blood cells 0.516713 plasma cell neoplasm 0.43097 radiation therapy 0.450659 Treatment Editorial Board 0.365249 General information 0.366352	treatment 0.57038 skeletal bone survey 0.42368 immature blood cells 0.371472 plasma cell tumor 0.384236 NCI-supported cancer 0.3737 cancer cells 0.440163 normal blood cells 0.369334 specific cancer cells 0.38023 diagnose multiple myeloma 0.381187 patient 0.372697 treatment clinical trials 0.388849 National Cancer Institute 0.392841 initial treatment 0.372799 new treatment 0.406543 plasma cells 0.480204 refractory multiple myeloma 0.365057 bone marrow 0.582695 healthy blood cells 0.378266 cells 0.557939 cancer clinical trials 0.42623 cancer 0.627272 information 0.418087 myeloma cells increases 0.397071 plasma cell neoplasms 0.895903	CLICK HERE
1638	National Cancer Institute	Html	en	Essiac/Flor Essence (PDQ®)–Patient Version	Essiac and Flor Essence are herbal tea mixtures first developed in Canada that are thought to remove toxins and poisons from the body and strengthen the immune system, although this has not been proven in cancer patients. Read about the history of Essiac and Flor Essence, the theory behind its use, and the results of laboratory, animal, and human studies.	Essiac formula 0.502569 peer-reviewed scientific journals 0.490423 cancer treatment 0.454247 cancer prevention 0.375568 Complementary Therapies Editorial 0.416551 Kill cancer cells 0.376017 breast cancer patient 0.382628 Drug Administration 0.400504 Cancer Information Specialist 0.387931 Flor Essence 0.977313 Flor Essence state 0.48205 herbal dietary supplements 0.446297 Flor Essence formulas 0.482148 Cancer Information Service 0.448298 Essiac 0.851494 Essiac herbal teas 0.514938 PDQ cancer information 0.515287 health tonics 0.425459 Cancer Complementary 0.397385 Flor Essence products 0.478002 CAM therapies 0.376991 prostate cancer cells 0.376887 Flor Essence tea 0.479505 National Cancer Institute 0.598699	studies 0.410222 Sloan-Kettering Cancer Center 0.381887 clinical trials 0.491591 Royal Cancer Commission 0.384396 alternative medicine 0.441037 health care 0.376403 cancer information summary 0.466243 alternative cancer therapies 0.394811 Federal Trade Commission 0.379856 clinical trial 0.417042 cancer cells 0.389663 Essiac/Flor Essence 0.431725 CAM cancer research 0.383472 herbal tea mixtures 0.394707 cancer patients 0.424798 NCI PDQ cancer 0.416273 cancer information database 0.392781 effects 0.382227 alternative therapies 0.415163 cancer information summaries 0.394001 Therapies Editorial Board 0.400185 cancer 0.660273 research studies 0.398662	CLICK HERE
1644	National Cancer Institute	Html	en	Gerson Therapy (PDQ®)–Patient Version	Expert-reviewed information summary about the use of the Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	treatment 0.476929 cancer treatment 0.426084 cancer prevention 0.384318 Complementary Therapies Editorial 0.435586 Cancer Information Specialist 0.399657 Drug Administration 0.382514 body 0.378493 Cancer Information Service 0.518118 PDQ cancer information 0.525476 Cancer Complementary 0.410407 CAM therapies 0.388339 Gerson’s therapy 0.456461 treatment clinical trials 0.381128 Gerson therapy reports 0.478587 National Cancer Institute 0.663474 clinical trials 0.562754 Dr. Gerson 0.569329 alternative medicine 0.46145 health care providers 0.421555 health care 0.444706 cancer information summary 0.471527 Max B. Gerson 0.46509 Gerson Research Organization 0.453179 alternative cancer therapies 0.404484	Federal Trade Commission 0.391653 National Institutes 0.385207 clinical trial 0.399404 National Center 0.376357 CAM cancer research 0.391227 new treatment 0.374685 breast cancer prevention 0.381892 patients 0.477683 cancer patients 0.443285 Cancer Care page 0.385186 latest published information 0.376378 key parts 0.39704 NCI’s PDQ 0.381863 PDQ summary 0.408051 Integrative Health 0.376266 NCI PDQ cancer 0.437412 cancer information database 0.407023 alternative therapies 0.430873 cancer information summaries 0.407395 Therapies Editorial Board 0.414248 cancer 0.692284 gerson therapy 0.948648 cancer information 0.545756	CLICK HERE
1685	National Cancer Institute	Html	en	Cannabis and Cannabinoids (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of Cannabis and cannabinoids in the treatment of cancer-related side effects, such as nausea and vomiting.	cannabinoid receptor CB2 0.721549 cancer cell proliferation 0.723514 opioid-treated cancer patients 0.721253 lung cancer 0.774703 testicular germ cell 0.736506 Cannabis trials 0.713054 endogenous cannabinoids 0.733591 bladder cancer 0.72104 clinical trials 0.71653 cannabinoid receptors 0.745589 advanced cancer patients 0.745457 CBD oromucosal spray 0.730536 cancer cell invasiveness 0.726743 Cancer Res 0.716198 cancer patients 0.801404 Investigational New Drug 0.714731 non-small cell lung 0.751006 effects 0.733811 colorectal cancer cell 0.727697 cancer chemotherapy 0.737056 cannabinoids 0.838589 et al. 0.767053 treatment 0.713465 study 0.761272 CBD 0.77215	United States 0.780596 Cannabis plant 0.728018 orally administered Cannabis 0.721336 Cancer Epidemiol Biomarkers 0.717008 cancer cell lines 0.803788 cannabinoid receptor 0.74565 THC 0.76674 Cannabis extract 0.739506 lung cancer chemotherapy 0.709535 cancer cell invasion 0.72445 breast cancer cell 0.789227 Cancer pain results 0.7118 cancer pain 0.721348 open-label extension study 0.709343 advanced cancer 0.748132 cell death 0.806928 Abstract 0.744659 cannabis 0.92504 germ cell tumors 0.735413 medicinal Cannabis 0.751597 cell lung cancer 0.728336 Cannabis species 0.726958 cancer 0.952946 Guidelines recommend cannabinoids 0.714742	CLICK HERE
1825	National Cancer Institute	Html	es	Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento cáncer de hígado infantil.	liver tumors 0.936797 Pediatric Oncology 0.824708 PRETEXT III 0.10879 Aronson DC 0.0851201 results from 0.266716 Paediatric Oncology 0.0823629 international pediatric liver 0.110029 Tumor Study Group 0.204309 standard-risk hepatoblastoma 0.125193 childhood liver tumors 0.0905382 Study Group 0.298822 Maibach R 0.0922692 hepatocellular carcinoma 0.861587 International Society 0.42048 IV hepatoblastoma 0.218263 Krailo MD 0.0915991 cog liver tumors 0.124853 Children's Oncology Group 0.248758 Estados Unidos 0.091099 hepatoblastoma with 0.740659 pediatric liver tumors 0.222622 hepatoblastoma after chemotherapy 0.124744 Pediatric Oncology Liver 0.123326 childhood hepatoblastoma 0.552956 with hepatoblastoma 0.638805	Perilongo G 0.171974 PRETEXT IV 0.0802866 grupos pretext 0.174753 Group intergroup study 0.0861929 Pediatr Blood Cancer 0.319797 Oncology Group study 0.119848 childhood liver 0.102417 Japanese Study Group 0.0968813 report from 0.211803 Childrens Cancer Study 0.0958008 quimioterapia preoperatoria 0.196007 Hepatoblastoma presenting with 0.134427 Liver Tumor Study 0.217304 Pediatr Surg 0.270609 Clin Oncol 0.979661 Hepatoblastoma metastatic 0.11507 Otte JB 0.0939222 Children's Cancer Group 0.202883 Shafford E 0.259892 prospective study 0.154606 Oncology Liver Tumor 0.132492 pediatric oncology group 0.588258 oncology group 0.803949 Cancer Study Group 0.108904	CLICK HERE
2035	National Cancer Institute	Html	es	Prevención del cáncer de próstata (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre los factores que pueden influir en el riesgo de cáncer de próstata y sobre la investigación dirigida a la prevención de esta enfermedad.	Cancer Events Trial 0.485531 principal hormona 0.450019 hiperplasia prostática benigna 0.693996 siguientes aspectos 0.54196 voluntarios sanos 0.443459 sistema urinario masculino 0.492083 protección baje 0.460121 sexuales masculinas 0.54225 características sexuales masculinas 0.494615 productos lácteos 0.532437 National Cancer Institute 0.461613 causa problemas 0.446148 siguientes riesgos 0.444876 alto contenido 0.439101 vitamina e 0.679303 Instituto Nacional 0.499716 hormonas masculinas 0.456898	hormonas sexuales masculinas 0.490983 Cancer Prevention Trial 0.881744 próstata.ampliar próstata 0.748136 ensayo pcpt 0.447994 siguientes factores 0.946442 Physician Data Query 0.60903 Estados Unidos 0.553599 suficiente ejercicio 0.453444 prevención revisa 0.462505 Antecedentes familiares 0.554865 PDQ Prevención 0.512729 aparato reproductor masculino 0.494928 Prostate Cancer Prevention 0.495264 suficiente folato 0.56107 Prostate Cancer 0.530877 siguientes sumarios 0.505076	CLICK HERE
2111	National Cancer Institute	Html	es	Exámenes de detección del cáncer de esófago (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de esófago.	PDQ Exámenes 0.728989 Physician Data Query 0.906997 libre uso 0.636785 prevención revisa 0.652274 información ayuda 0.682663 vías respiratorias 0.673206	carcinoma epidermoide 0.760269 National Cancer Institute 0.66546 cáncer.ampliar esofagoscopía 0.714851 siguientes riesgos 0.649549 siguientes sumarios 0.849506 Instituto Nacional 0.740034	CLICK HERE
17289	National Cancer Institute	Html	es	Servicios de apoyo	Servicios disponibles para ayudarle a superar problemas durante el tratamiento del cáncer y después del mismo.			CLICK HERE